The World’s Worst Stock Market Is Not Cheap Enough to Buy
(Bloomberg) -- For some Philippine money managers, it's still too soon to scoop up shares in the world's worst-performing stock market.
As the Philippine Stock Exchange Index dipped below 7,100 during Tuesday's session, taking its valuation to its lowest level since January 2016, Metropolitan Bank & Trust Co. is among the firms that's staying on the sidelines. John Padilla, the head of equities at the money manager, says he's too concerned about the high inflation level, rising oil prices, weakening peso, increasing interest rates and drying up liquidity.
“Everybody is bracing and positioning for a higher inflation, and with oil continuing its climb there isn't anything to say that's enticing to go bargain hunting at this point,” said Padilla, who helps manage 450 billion pesos ($8.3 billion). “It used to be that a buy-on-weakness strategy works, but now for prudence it's better to step aside and let the market take its course.”
The Philippine Stock Exchange has plunged 17 percent since the end of December, becoming the world's biggest losing equity market and taking its valuation to 15 times estimated earnings for the next year, below its five-year average. The gauge fell as much as 0.5 percent to 7,095.26 on Wednesday.
The recent sell-off from emerging markets and U.S.-China trade frictions only added to worries over the nation's headwinds. Overseas investors have withdrawn almost $1.6 billion in 2018, exceeding inflows from the past four years.
Padilla said it's not improbable for the Philippine stock gauge to fall below 7,000 in the near term and that it could go as low as 6,600. He said his firm will change its underweight call on the equities should consumer prices, the peso, interest rates and liquidity show improvements. September inflation data are due on Friday.
“You can get a better return with your cash in time deposit now rather than exposing it to equities, where at best you get a flat return but run the risk of losing part of your money if you buy the wrong name,” Padilla said.
The country's shares will face more challenges before things get better, according to Michael Enriquez, the chief investment officer of Sun Life of Canada Philippines Inc. The PSEi could stay at around 7,100 this year, with earnings growth of 5.5 percent compared with 10 percent to 12 percent consensus, he said. To put that into perspective, the key stock gauge closed at almost 8,559 at the end of last year.
Steven Ko, who helps manage 60 billion pesos at Rizal Commercial Banking Corp., sees further risk as limited. While the benchmark index may drop to 6,900, he says there's also a chance it could climb to 8,000 this year as sentiment improves. He expects inflation to peak and says the peso may have already seen its sharpest depreciation this year.
“We are still holding on to our cash, but we are selectively buying some of the oversold names that are already worth looking into,” Ko said. He favors property stocks because he sees higher earnings-growth prospects and likes banks as he deems them unduly hit by the rout.
To contact the reporter on this story: Ian Sayson in Manila at isayson@bloomberg.net
To contact the editors responsible for this story: Divya Balji at dbalji1@bloomberg.net, Cecile Vannucci
©2018 Bloomberg L.P.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.